Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xiaodong Wang Insider Profile
4 Followers
Xiaodong Wang, Director, Chair, Scientific Advisory Brd at BeiGene, holds 10.32M shares in BeiGene (Ticker: BGNE).
Xiaodong Wang BeiGene (BGNE)Director, Chair, Scientific Advisory Brd
BeiGene (BGNE)
Director, Chair, Scientific Advisory Brd
Ranked #86,435 out of 99,797 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-36.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director, Chair, Scientific Advisory Brd
Roles that Xiaodong Wang holds in companies
Most Profitable Insider Trade
The most profitable trade made by Xiaodong Wang
Xiaodong Wang's Trading History
List of latest transactions for each holding click on a transaction to see Xiaodong Wang's performance on stock
You May Also Like
Xiaodong Wang insider profile FAQ
What is the percentage of profitable transactions made by Xiaodong Wang?
The percentage of profitable transactions made by Xiaodong Wang is 50%.
What is the average return per transaction made by Xiaodong Wang?
The average return per transaction made by Xiaodong Wang is -36.60%.
What stocks does Xiaodong Wang hold?
Xiaodong Wang holds: BGNE stocks.
What was Xiaodong Wang’s latest transaction?
Xiaodong Wang latest transaction was an Uninformative Buy of $271.44K.
What was Xiaodong Wang's most profitable transaction?
Xiaodong Wang’s most profitable transaction was an Informative Sell of BGNE stock on March 10, 2023. The return on the trade was 26.60%.
What is Xiaodong Wang's role in BeiGene?
Xiaodong Wang's role in BeiGene is Director, Chair, Scientific Advisory Brd.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.